Production (Stage)
Synaptogenix, Inc.
SNPX
$2.42
$0.167.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.83% | 12.84% | -6.64% | -18.63% | -47.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.79% | 2.17% | -4.90% | -13.59% | -42.11% |
| Operating Income | 36.79% | -2.17% | 4.90% | 13.59% | 42.11% |
| Income Before Tax | 286.36% | -456.88% | -852.36% | 68.90% | 87.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 286.36% | -456.88% | -852.36% | 68.90% | 87.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 286.36% | -456.88% | -852.36% | 68.90% | 87.92% |
| EBIT | 36.79% | -2.17% | 4.90% | 13.59% | 42.11% |
| EBITDA | 36.80% | -2.17% | 4.91% | 13.58% | 42.13% |
| EPS Basic | 129.53% | -187.08% | -442.87% | 96.58% | 93.78% |
| Normalized Basic EPS | 239.41% | -62.02% | -344.06% | 92.41% | 96.50% |
| EPS Diluted | 109.78% | -187.08% | -442.87% | 96.58% | 93.78% |
| Normalized Diluted EPS | 238.68% | -62.02% | -344.06% | 92.41% | 96.50% |
| Average Basic Shares Outstanding | 33.66% | 60.23% | 208.27% | 309.71% | 245.45% |
| Average Diluted Shares Outstanding | 34.36% | 60.23% | 208.27% | 309.71% | 245.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 1.00% | -- | -- | -- |